Leerink Swann assumed coverage on shares of Livongo Health (NASDAQ:LVGO) in a research report sent to investors on Monday morning, The Fly reports. The brokerage issued an outperform rating and a $50.00 target price on the stock.
A number of other research firms have also recently commented on LVGO. Chardan Capital began coverage on Livongo Health in a research note on Friday, August 16th. They set a neutral rating and a $40.00 target price on the stock. Piper Jaffray Companies began coverage on Livongo Health in a research note on Monday. They set an overweight rating and a $40.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of Buy and a consensus price target of $44.20.
LVGO opened at $34.95 on Monday. Livongo Health has a one year low of $31.60 and a one year high of $45.68.
About Livongo Health
Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.
Read More: 52-Week High/Low Prices For Stock Selection
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.